Last reviewed · How we verify
Vonoprazan ODT-1 or ODT-2 without Water — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Vonoprazan ODT-1 or ODT-2 without Water (Vonoprazan ODT-1 or ODT-2 without Water) — Phathom Pharmaceuticals, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vonoprazan ODT-1 or ODT-2 without Water TARGET | Vonoprazan ODT-1 or ODT-2 without Water | Phathom Pharmaceuticals, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vonoprazan ODT-1 or ODT-2 without Water CI watch — RSS
- Vonoprazan ODT-1 or ODT-2 without Water CI watch — Atom
- Vonoprazan ODT-1 or ODT-2 without Water CI watch — JSON
- Vonoprazan ODT-1 or ODT-2 without Water alone — RSS
Cite this brief
Drug Landscape (2026). Vonoprazan ODT-1 or ODT-2 without Water — Competitive Intelligence Brief. https://druglandscape.com/ci/vonoprazan-odt-1-or-odt-2-without-water. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab